247 related articles for article (PubMed ID: 15108807)
1. Ski and SnoN: negative regulators of TGF-beta signaling.
Luo K
Curr Opin Genet Dev; 2004 Feb; 14(1):65-70. PubMed ID: 15108807
[TBL] [Abstract][Full Text] [Related]
2. [Ski and SnoN: antagonistic proteins of TGFbeta signaling].
Vignais ML
Bull Cancer; 2000 Feb; 87(2):135-7. PubMed ID: 10705283
[TBL] [Abstract][Full Text] [Related]
3. [Role of Ski/SnoN protein in the regulation of TGF-beta signal pathway].
Lu ZH; Chen J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Apr; 25(2):233-6. PubMed ID: 12905729
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of the expression of c-Ski and SnoN, possible mediators in TGF-beta resistance, in primary cutaneous melanoma.
Boone B; Haspeslagh M; Brochez L
J Dermatol Sci; 2009 Jan; 53(1):26-33. PubMed ID: 18782659
[TBL] [Abstract][Full Text] [Related]
5. Involvement of the constitutive complex formation of c-Ski/SnoN with Smads in the impaired negative feedback regulation of transforming growth factor beta signaling in scleroderma fibroblasts.
Jinnin M; Ihn H; Mimura Y; Asano Y; Tamaki K
Arthritis Rheum; 2007 May; 56(5):1694-705. PubMed ID: 17469184
[TBL] [Abstract][Full Text] [Related]
6. SnoN co-repressor binds and represses smad7 gene promoter.
Briones-Orta MA; Sosa-Garrocho M; Moreno-Alvarez P; Fonseca-Sánchez MA; Macías-Silva M
Biochem Biophys Res Commun; 2006 Mar; 341(3):889-94. PubMed ID: 16442497
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of Ski and SnoN co-repressors by anisomycin.
Vázquez-Macías A; Ruíz-Mendoza AB; Fonseca-Sánchez MA; Briones-Orta MA; Macías-Silva M
FEBS Lett; 2005 Jul; 579(17):3701-6. PubMed ID: 15967445
[TBL] [Abstract][Full Text] [Related]
8. c-Ski inhibits the TGF-beta signaling pathway through stabilization of inactive Smad complexes on Smad-binding elements.
Suzuki H; Yagi K; Kondo M; Kato M; Miyazono K; Miyazawa K
Oncogene; 2004 Jun; 23(29):5068-76. PubMed ID: 15107821
[TBL] [Abstract][Full Text] [Related]
9. A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition.
Yang J; Dai C; Liu Y
J Am Soc Nephrol; 2005 Jan; 16(1):68-78. PubMed ID: 15537870
[TBL] [Abstract][Full Text] [Related]
10. Fussel-15, a novel Ski/Sno homolog protein, antagonizes BMP signaling.
Arndt S; Poser I; Moser M; Bosserhoff AK
Mol Cell Neurosci; 2007 Apr; 34(4):603-11. PubMed ID: 17292623
[TBL] [Abstract][Full Text] [Related]
11. Ski/SnoN expression in the sequence metaplasia-dysplasia-adenocarcinoma of Barrett's esophagus.
Villanacci V; Bellone G; Battaglia E; Rossi E; Carbone A; Prati A; Verna C; Niola P; Morelli A; Grassini M; Bassotti G
Hum Pathol; 2008 Mar; 39(3):403-9. PubMed ID: 18261624
[TBL] [Abstract][Full Text] [Related]
12. Ski-related novel protein N (SnoN), a negative controller of transforming growth factor-beta signaling, is a prognostic marker in estrogen receptor-positive breast carcinomas.
Zhang F; Lundin M; Ristimäki A; Heikkilä P; Lundin J; Isola J; Joensuu H; Laiho M
Cancer Res; 2003 Aug; 63(16):5005-10. PubMed ID: 12941827
[TBL] [Abstract][Full Text] [Related]
13. Inability of transforming growth factor-beta to cause SnoN degradation leads to resistance to transforming growth factor-beta-induced growth arrest in esophageal cancer cells.
Edmiston JS; Yeudall WA; Chung TD; Lebman DA
Cancer Res; 2005 Jun; 65(11):4782-8. PubMed ID: 15930298
[TBL] [Abstract][Full Text] [Related]
14. Cytoplasmic localization of the oncogenic protein Ski in human cutaneous melanomas in vivo: functional implications for transforming growth factor beta signaling.
Reed JA; Bales E; Xu W; Okan NA; Bandyopadhyay D; Medrano EE
Cancer Res; 2001 Nov; 61(22):8074-8. PubMed ID: 11719430
[TBL] [Abstract][Full Text] [Related]
15. The transforming activity of Ski and SnoN is dependent on their ability to repress the activity of Smad proteins.
He J; Tegen SB; Krawitz AR; Martin GS; Luo K
J Biol Chem; 2003 Aug; 278(33):30540-7. PubMed ID: 12764135
[TBL] [Abstract][Full Text] [Related]
16. Nuclear and cytoplasmic c-Ski differently modulate cellular functions.
Nagata M; Goto K; Ehata S; Kobayashi N; Saitoh M; Miyoshi H; Imamura T; Miyazawa K; Miyazono K
Genes Cells; 2006 Nov; 11(11):1267-80. PubMed ID: 17054724
[TBL] [Abstract][Full Text] [Related]
17. Loss of c-myc repression coincides with ovarian cancer resistance to transforming growth factor beta growth arrest independent of transforming growth factor beta/Smad signaling.
Baldwin RL; Tran H; Karlan BY
Cancer Res; 2003 Mar; 63(6):1413-9. PubMed ID: 12649207
[TBL] [Abstract][Full Text] [Related]
18. Influence of melanoma inhibitory activity on transforming growth factor-beta signaling in malignant melanoma.
Rothhammer T; Bosserhoff AK
Melanoma Res; 2006 Aug; 16(4):309-16. PubMed ID: 16845326
[TBL] [Abstract][Full Text] [Related]
19. Ski and SnoN, potent negative regulators of TGF-beta signaling.
Deheuninck J; Luo K
Cell Res; 2009 Jan; 19(1):47-57. PubMed ID: 19114989
[TBL] [Abstract][Full Text] [Related]
20. Cytoplasmic SnoN in normal tissues and nonmalignant cells antagonizes TGF-beta signaling by sequestration of the Smad proteins.
Krakowski AR; Laboureau J; Mauviel A; Bissell MJ; Luo K
Proc Natl Acad Sci U S A; 2005 Aug; 102(35):12437-42. PubMed ID: 16109768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
